Abstract Details

Title Evaluating the Safety and Efficacy of Transitioning Multiple Sclerosis Patients from Natalizumab to Rituximab

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 187

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
James Stark, MD, FAAN (IMSMP) PRESENTER	Dr. Stark has nothing to disclose.
Armistead Williams III, MD (International MS Management Practice)	Dr. Williams has nothing to disclose.
Saud Sadiq, BS, FAAN (Tisch Multiple Sclerosis Research Center of New York)	Ms. Brewi has nothing to disclose.

��ɫ����